{"news_desk": "Business", "print_page": "11", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By CHAD BRAY", "person": [{"rank": 1, "role": "reported", "firstname": "Chad", "organization": "", "lastname": "BRAY"}]}, "abstract": "Irish drug maker Shire agrees to acquire American biotechnology firm Dyax Corporation for up to $6.5 billion.", "type_of_material": "News", "word_count": "457", "lead_paragraph": "The transaction would be the latest in an acquisition spree by Shire since its tentative agreement to be bought by the drug maker AbbVie was terminated.", "pub_date": "2015-11-03T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Irish Drug Maker Shire Agrees to Buy Dyax in Deal Worth Up to $6.5 Billion", "print_headline": "Irish Drug Maker Shire Agrees to Buy Dyax in Deal Worth Up to $6.5 Billion"}, "snippet": "The transaction would be the latest in an acquisition spree by Shire since its tentative agreement to be bought by the drug maker AbbVie was terminated.", "multimedia": [{"height": 126, "url": "images/2015/11/03/business/db-shire-web1/db-shire-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/11/03/business/db-shire-web1/db-shire-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/11/03/business/db-shire-web1/db-shire-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/11/03/business/db-shire-web1/db-shire-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/11/03/business/db-shire-web1/db-shire-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/11/03/business/db-shire-web1/db-shire-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/03/business/dealbook/shire-dyax-corp-deal.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Dyax Corporation", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Shire PLC", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "AbbVie Inc", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Baxter International", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "NPS Pharmaceuticals Inc", "name": "organizations"}, {"rank": "9", "is_major": "N", "value": "Salix Pharmaceuticals Ltd", "name": "organizations"}], "blog": [], "_id": "56376b0f38f0d829bdc68687", "source": "The New York Times"}